Results 1 to 10 of about 63,763 (256)

Hepatitis B and the Need for a Booster Dose [PDF]

Clinical Infectious Diseases, 2011
After several decades of vaccination against hepatitis B virus in newborns, infants, adolescents, and adults, the question remains whether a booster dose is ever needed. Long-term protection is most commonly measured through 4 methods: the anamnestic response after administration of a booster dose, infection rate in vaccinated populations, in vitro B ...
Leuridan, Elke, van Damme, Pierre
openaire   +5 more sources

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland [PDF]

Vaccines, 2021
COVID-19 vaccinations are essential to mitigate the pandemic and prevent severe SARS-CoV-2 infections. However, the serum antibody levels in vaccinated individuals gradually decrease over time, while SARS-CoV-2 is undergoing an evolution toward more transmissible variants, such as B.1.617.2, ultimately increasing the risk of breakthrough infections and
Barbara Poniedziałek, Piotr Rzymski, Andrzej Fal   +2 more
exaly   +4 more sources

A survey on Malaysian's acceptance and perceptions towards COVID-19 booster dose. [PDF]

Saudi Pharm J, 2023
Progressive reopening of the economy and declaration of COVID-19 as endemic has relaxed social distancing and mask-wearing necessities in Malaysia. The Ministry of Health of Malaysia reported vaccination rate had reached 86.1% for the first dose and 84.3%
Rajakumar S, Shamsuddin N, Alshawsh MA, Rajakumar S, Zaman Huri H.   +4 more
europepmc   +2 more sources

Uptake of COVID-19 Booster Dose among Saudi Arabian Population [PDF]

, 2022
Backgroundand objectives: Although several vaccines have been produced and administered around the world, new SARS-CoV-2 worsened the COVID-19 infection risk and impacted the initial vaccine dosage effectiveness.
Rashid, Harunor, Najim Z. Alshahrani, Abdullah A. Alsabaani, Harunor Rashid, Alsabaani, Abdullah A., Alshahrani, Najim Z., Ridda, Iman, Bader Ahmed S. Alzahrani, Almutairi, Talal Hamed, Talal Hamed Almutairi, Alzahrani, Faris, Abdulelah Saleh Saeed Albeshri, Faris Alzahrani, Alzahrani, Bader Ahmed S., Iman Ridda, Albeshri, Abdulelah Saleh Saeed   +15 more
core   +1 more source

Acceptance for a booster dose of COVID-19 vaccine in Indonesia: A follow-up study. [PDF]

Narra J
The coronavirus disease 2019 (COVID-19) vaccination program in Indonesia has been implemented as a key strategy to mitigate the spread of the virus within communities.
Harapan H, Maelani I, Anwar S, Latief K, Mellinia SA, Nanda CM, Nainu F, Nirwana A, Aksa R, Sarifuddin S, Astri Y, Fathima R, Nalapraya WY, Ikram I, Mutiara S, Syahraini A, Mudatsir M.   +16 more
europepmc   +3 more sources

Factors underlying COVID-19 booster vaccine uptake among fully vaccinated adults in Belgium [PDF]

, 2023
Background To tackle waning protection against severe COVID-19 infection, booster doses of the COVID-19 vaccines were recommended among individuals who received their primary course.
L. Catteau, J. Van Loenhout, E. Vermeiren, V. Stouten, I. Van Evercooren, P. Hubin, M. Billuart, L. Nasiadka   +7 more
core   +2 more sources

COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022 [PDF]

, 2023
The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose for all persons >18 years of age. We analyzed data from the National Immunization Survey–Adult COVID Module collected during February 27–March 26, 2022 to assess ...
Kushagra Vashist, Lu Meng, James A. Singleton, Hannah E. Fast, Anup Srivastav, Tianyi Zhou, Carla L. Black, Peng-jun Lu, David Yankey, Hilda Razzaghi, Mei-Chuan Hung, Jennifer L. Kriss, Nina B. Masters   +12 more
core   +1 more source

COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis [PDF]

, 2022
The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-19) booster dose vaccination after completing the primary vaccination series for individuals ≥18 years and most-at-risk populations.
Ramy Mohamed Ghazy, Ghazy, Ramy Mohamed, Shaimaa Abdelaziz Abdelmoneim, Mohammed Fathelrahman Adam, Manal Naguib, Adam, Mohammed Fathelrahman, Hafez, Dina Mohamed, Aji, Narjiss, Malik Sallam, Ahmed El-Sayed Nour El-Deen, Sally Waheed Elkhadry, Abdelmoneim, Shaimaa Abdelaziz, Dina Mohamed Hafez, Hammad, Elsayed Mohamed, Amr Abdelraouf Ghobashy, Sallam, Malik, Elrewany, Ehab, Mousli, Hesham Metwalli, Nour El-Deen, Ahmed El-Sayed, Narjiss Aji, Elkhadry, Sally Waheed, Ghobashy, Amr Abdelraouf, Naguib, Manal, Ehab Elrewany, Hesham Metwalli Mousli, Elsayed Mohamed Hammad   +25 more
core   +1 more source

Efficacy of HBV booster dose administration in Italian medical students in relation to health determinants. [PDF]

Hum Vaccin Immunother
: We evaluated the efficacy of a booster dose of HBV in Italian medical students. We conducted a prospective observational study in students who had received a full course of anti-HBV vaccination for at least 15 y. Those with an anti-HBs titer <10 mIU/
Tobia L, Zagà RF, Mattei A, Cipollone C, Cipriani A, Sedile AI, Fabiani L, Bianchi S.   +7 more
europepmc   +2 more sources

Booster dose vaccination for preventing hepatitis B [PDF]

Cochrane Database of Systematic Reviews, 2016
Antibodies against hepatitis B surface antigen (HBsAg) wane over time following hepatitis B immunisation; hence, it is unclear whether people vaccinated in three-dose or four-dose schedules of the hepatitis B vaccine are still immune when the hepatitis B surface antibody (anti-HBs) level in their body is undetectable, or lower than the level usually ...
Jalal, Poorolajal, Elham, Hooshmand
openaire   +2 more sources